METTL3 has been shown to have a tumor-promoting role in many cancers (Deng et al, 2018) and its inhibition through small molecules has recently been proposed as a therapeutic strategy for acute myeloid leukemia (AML) (Yankova et al, 2021). This evidence concerns the gene METTL3 and acute myeloid leukemia.